Nonparametric population pharmacokinetic model of Amikacin in respiratory critical ill patients

被引：0
|
作者：
Riff, C. [1 ]
Woillard, J. B. [1 ]
Hraiech, S. [2 ]
Woloch, C. [1 ]
Marsot, A. [3 ]
Guilhaumou, R. [3 ]
Blin, O. [3 ]
Saint-Marcoux, F. [1 ]
机构：
[1] CHU Limoges, Lab Pharmacol Toxicol & Pharmacovigilance, Limoges, France
[2] Hop Nord Marseille, Serv Reanimat Med Detresses Resp, Infect Severes, Marseille, France
[3] Aix Marseille Univ, AMU CNRS 7289, Serv Pharmacol Clin & Pharmacovigilance, Inst Neurosci Timone,AP HM,Pharmacol Integree & I, Marseille, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2016年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
CO-059
引用
收藏
页码：18 / 18
页数：1
相关论文
共 50 条
  • [21] Population pharmacokinetic parameters of vancomycin in critically ill patients
    Llopis-Salvia, P.
    Jimenez-Torres, N. V.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2006, 31 (05) : 447 - 454
  • [22] Quantification and Explanation of the Variability of First-Dose Amikacin Concentrations in Critically Ill Patients Admitted to the Emergency Department: A Population Pharmacokinetic Analysis
    Sabrina De Winter
    Reinier van Hest
    Erwin Dreesen
    Pieter Annaert
    Joost Wauters
    Wouter Meersseman
    Nele Van den Eede
    Stefanie Desmet
    Sandra Verelst
    Peter Vanbrabant
    Willy Peetermans
    Isabel Spriet
    European Journal of Drug Metabolism and Pharmacokinetics, 2021, 46 : 653 - 663
  • [23] Quantification and Explanation of the Variability of First-Dose Amikacin Concentrations in Critically Ill Patients Admitted to the Emergency Department: A Population Pharmacokinetic Analysis
    De Winter, Sabrina
    van Hest, Reinier
    Dreesen, Erwin
    Annaert, Pieter
    Wauters, Joost
    Meersseman, Wouter
    Van den Eede, Nele
    Desmet, Stefanie
    Verelst, Sandra
    Vanbrabant, Peter
    Peetermans, Willy
    Spriet, Isabel
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2021, 46 (05) : 653 - 663
  • [24] Clinical Pharmacokinetics of Amikacin in Pediatric Patients: A Comprehensive Review of Population Pharmacokinetic Analyses
    Illamola, Silvia M.
    Sherwin, Catherine M.
    van Hasselt, J. G. Coen
    CLINICAL PHARMACOKINETICS, 2018, 57 (10) : 1217 - 1228
  • [25] Clinical Pharmacokinetics of Amikacin in Pediatric Patients: A Comprehensive Review of Population Pharmacokinetic Analyses
    Sílvia M. Illamola
    Catherine M. Sherwin
    J. G. Coen van Hasselt
    Clinical Pharmacokinetics, 2018, 57 : 1217 - 1228
  • [26] Nonparametric population pharmacokinetic modeling fvancomycin
    Shinozaki, K
    Oshima, K
    Sako, K
    Sato, M
    THERAPEUTIC DRUG MONITORING, 2005, 27 (02) : 252 - 253
  • [27] Nonparametric population pharmacokinetic modeling of flecainide
    Uehara, A
    Shinozaki, K
    Sako, K
    Shimada, M
    Baba, A
    Akaishi, M
    THERAPEUTIC DRUG MONITORING, 2005, 27 (02) : 256 - 257
  • [28] Population pharmacokinetics of four β-lactams in critically ill septic patients comedicated with amikacin
    Delattre, Isabelle K.
    Musuamba, Flora T.
    Jacqmin, Philippe
    Taccone, Fabio S.
    Laterre, Pierre-Francois
    Verbeeck, Roger K.
    Jacobs, Frederique
    Wallemacq, Pierre
    CLINICAL BIOCHEMISTRY, 2012, 45 (10-11) : 780 - 786
  • [29] HEMODIALYSIS OF AMIKACIN IN CRITICALLY ILL PATIENTS
    ARMSTRONG, D
    HODGMAN, T
    VISCONTI, J
    REILLEY, T
    TRAETOW, D
    DASTA, J
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1983, 17 (06): : 437 - 437
  • [30] HEMODIALYSIS OF AMIKACIN IN CRITICALLY ILL PATIENTS
    ARMSTRONG, DK
    HODGMAN, T
    VISCONTI, JA
    REILLEY, TE
    GARNER, WL
    DASTA, JF
    CRITICAL CARE MEDICINE, 1988, 16 (05) : 517 - 520
12345